Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines.
BACKGROUND
After the advent of absolute fracture risk calculators, guidelines for the management of osteoporosis released by the U.S.-based National Osteoporosis Foundation (NOF) and the U.K.-based National Osteoporosis Guidelines Group (NOGG) differ markedly in their approaches to treatment recommendations.


OBJECTIVE
The aim of the study was to apply the NOF and NOGG guidelines to a cohort of older women and compare the treatment recommendations with fracture outcomes over 5 yr for each algorithm.


METHODS
We conducted a cohort study of women who participated in a 5-yr randomized controlled trial of calcium supplementation at a clinical research center.


METHODS
We studied 1471 healthy, community-dwelling, older women with mean age of 74 yr and mean follow-up of 4.4 yr.


METHODS
A total of 143 subjects (10%) sustained a nontraumatic osteoporotic fracture, and 21 sustained a nontraumatic hip fracture (1.4%).


RESULTS
Applying the NOF guidelines required that 97% of participants undergo bone densitometry and 48% receive treatment. Seventy-six percent of hip fracture cases and 63% of osteoporotic fracture cases were identified for treatment. Applying the NOGG guidelines required that 13% of participants undergo bone densitometry and 21% receive treatment. Thirty-eight percent of hip fracture cases and 27% of osteoporotic fracture cases were identified for treatment.


CONCLUSIONS
Treatment recommendations and fracture outcomes in older, predominantly osteopenic women differ substantially according to the management guideline applied. The NOGG guidelines identify only a minority of fracture cases; the NOF guidelines identify the majority of fracture cases, but at the expense of greater resource utilization. Both strategies lead to recommendations for reassurance in significant numbers of women who subsequently sustain fragility fractures.
Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1142, New Zealand. m.bolland@auckland.ac.nz
Mark J
MJ
Bolland
Andrew
A
Grey
D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D015519:Bone Density; D002136:Calcium, Dietary / Q000627:therapeutic use; D015331:Cohort Studies; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology / Q000517:prevention & control; D006620:Hip Fractures / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000453:epidemiology / Q000628:therapy*; D017698:Postmenopause / Q000502:physiology; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D002136:Calcium, Dietary